Meningioma overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
'''Meningiomas''' are relatively common neoplasm of the central nervous system that arises from arachnoidal cells; the majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur; they have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and spinal canal.
'''Meningiomas''' are the most common [[benign]] [[tumor]]s of the [[brain]] (95% of benign tumors). However they can also be [[malignant]]. They arise from the arachnoidal cap cells of the [[meninges]] and represent about 15% of all primary brain tumors. They are more common in [[female]]s than in [[male]]s (2:1) and have a peak incidence in the sixth and seventh decades. Most cases are sporadic while some are familial. There has been some evidence that persons who have undergone [[radiation]] to the [[scalp]] are more at risk for developing meningiomas. The most frequent genetic mutations involved in meningiomas are inactivation mutations in the neurofibromatosis 2 [[gene]] (merlin) on [[chromosome]] 22q.
'''Meningiomas''' are the most common [[benign]] [[tumor]]s of the [[brain]] (95% of benign tumors). However they can also be [[malignant]]. They arise from the arachnoidal cap cells of the [[meninges]] and represent about 15% of all primary brain tumors. They are more common in [[female]]s than in [[male]]s (2:1) and have a peak incidence in the sixth and seventh decades. Most cases are sporadic while some are familial. There has been some evidence that persons who have undergone [[radiation]] to the [[scalp]] are more at risk for developing meningiomas. The most frequent genetic mutations involved in meningiomas are inactivation mutations in the neurofibromatosis 2 [[gene]] (merlin) on [[chromosome]] 22q.



Revision as of 14:05, 24 September 2015

Meningioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Meningioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Meningioma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Meningioma overview

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Meningioma overview

CDC on Meningioma overview

Meningioma overview in the news

Blogs on Meningioma overview

Directions to Hospitals Treating Meningioma

Risk calculators and risk factors for Meningioma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Meningiomas are relatively common neoplasm of the central nervous system that arises from arachnoidal cells; the majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur; they have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and spinal canal. Meningiomas are the most common benign tumors of the brain (95% of benign tumors). However they can also be malignant. They arise from the arachnoidal cap cells of the meninges and represent about 15% of all primary brain tumors. They are more common in females than in males (2:1) and have a peak incidence in the sixth and seventh decades. Most cases are sporadic while some are familial. There has been some evidence that persons who have undergone radiation to the scalp are more at risk for developing meningiomas. The most frequent genetic mutations involved in meningiomas are inactivation mutations in the neurofibromatosis 2 gene (merlin) on chromosome 22q.

References


Template:WikiDoc Sources